[34] Hattori T， Shimokawa H， Higashi M， et al. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice[J]. Circulation， 2004， 109： 2234.

    [35] Satoh K， Fukumoto Y， Shimokawa H. Rho-kinase： important new therapeutic target in cardiovascular diseases[J]. Am J Physiol Heart Circ Physiol， 2011， 301： H287.

    [36] Chandra S， Romero M， Shatanawi A， et al. Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway[J]. Br J Pharmacol ......